The University of Chicago Header Logo

Connection

Bulent Aydogan to Vidarabine

Back to Details
This is a "connection" page, showing publications Bulent Aydogan has written about Vidarabine.
Bulent Aydogan
Connection Strength
0.220
Vidarabine
  1. High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024 Jul; 113(1):110-116.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.